Exhibit 10.1
ASSET PURCHASE
AGREEMENT
This Asset Purchase Agreement (this
“ Agreement ”) is entered into as of
July 29, 2009 (“Effective Date”), by and among
PharmaCare US Inc., a Delaware corporation (“ PharmaCare
US ”), and PharmaCare Laboratories Pty Ltd., an
Australian company (“ PharmaCare Australia ”)
(PharmaCare US and PharmaCare Australia may be referred to herein
individually as “Buyer” and collectively as the “
Buyers ”), Real Health Laboratories, Inc., a
California corporation (“ Seller ”) and a
wholly-owned subsidiary of Natural Alternatives International,
Inc., a Delaware corporation (“ Parent ”), and
Parent. Buyers, Seller and Parent may be referred to herein
individually as a “ Party ” and collectively as
the “ Parties .”
WHEREAS, Buyers desire to purchase
from Seller certain assets used in (and assume certain of the
liabilities of Seller related to) Seller’s wholesale and
direct-to-consumer vitamin and nutritional supplement business (the
“ Business ”), which, for purposes of
clarification, does not include any assets or business related to
products manufactured, marketed, distributed or sold by Parent
including, without limitation, under the Parent’s
Dr. Cherry brand; and
WHEREAS, Seller desires to sell to
Buyers such assets and assign to Buyers such liabilities on the
terms set forth herein.
Now, therefore, in consideration of
the foregoing premises and the mutual promises herein made and the
representations, warranties and covenants herein contained, and for
other good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, the Parties agree as
follows.
Section 1. Definitions .
The definitions of certain defined terms, not defined elsewhere in
this Agreement, are:
“ Acquired Assets
” means all of Seller’s right, title, and interest in
and to the following, and only the following, specified
assets:
(a) the Acquired Intellectual
Property; and
(b) the Acquired
Inventory.
“ Acquired Intellectual
Property ” means the Intellectual Property listed on
Schedule 1 .
“ Acquired Inventory
” means the inventory of the Business listed on Schedule
2 , which schedule Buyers and Seller agree will be completed by
Seller and delivered to Buyers within ten (10) business days
after the Closing Date and will include all of the inventory of the
Business and inventories related to open purchase orders as of the
Closing Date.
“ Adverse Consequences
” means all actions, suits, proceedings, hearings,
investigations, charges, complaints, claims, demands, injunctions,
judgments, orders, decrees, rulings, damages, dues, penalties,
fines, costs, reasonable amounts paid in settlement, liabilities,
obligations, taxes, liens, losses, expenses, and fees, including
court costs and reasonable attorneys’ fees and
expenses.
“ Affiliate ” has
the meaning set forth in Rule 12b-2 of the regulations promulgated
under the Securities Exchange Act of 1934, as amended.
“ Assumed Liabilities
” means the following, and only the following, liabilities of
the Seller:
|
|
(a)
|
all obligations
for product returns from wholesalers from and after
October 29, 2009, including such obligations under
Seller’s return and exchange policies as such policies are
disclosed on Schedule 3(i) of Seller’s Disclosure
Schedule;
|
|
|
(b)
|
all obligations
for product returns in connection with the direct-to-consumer
portion of the Business from and after August 30, 2009,
including such obligations under Seller’s return and exchange
policies as such policies are disclosed on Schedule 3(i) of
Seller’s Disclosure Schedule;
|
|
|
(c)
|
all obligations
of Seller related to open purchase orders for Acquired
Inventory;
|
|
|
(d)
|
all obligations
of Seller from and after the Closing Date under that certain
Endorsement, Licensing and Sales Agreement effective as of
May 1, 2009, by and between Seller and Dr. Robert Fried,
which agreement shall be assigned by Seller to Buyers at the
Closing;
|
|
|
(e)
|
all obligations
of Seller from and after the Closing Date under that certain Coupon
Redemption Program Agreement dated as of April 6, 2006, by and
between Carolina Manufacturer’s Services, Inc. and Seller
(“ CMS Agreement ”); and
|
|
|
(f)
|
all obligations
of Seller from and after the Closing Date under that certain Patent
License Agreement dated as of May 1, 2002, by and between
Seller and Unither Pharma, Inc. (“ Unither Agreement
”), which agreement shall be assigned by Seller to Buyers at
the Closing.
|
provided , however , that the term “
Assumed Liabilities ” shall not include any of the
Excluded Liabilities.
“ Closing Date Net
Inventory Value ” means the Net Inventory Value, as of
12:01 a.m., San Diego time, on the Closing Date.
“ Code ” means
the Internal Revenue Code of 1986, as amended.
“ Confidentiality
Agreement ” means that certain Mutual Confidentiality and
Non-Disclosure Agreement entered into by and between Parent and
Pharmacare Australia, effective as of February 24,
2009.
“ Excluded Liabilities
” means any liability or obligation of Seller other than
those set forth in the definition of “Assumed
Liabilities,” including: (a) any liability arising out
of or relating to the operation of the Business by Seller,
including any liability relating to products manufactured or
distributed by or for Seller, prior to the Closing Date;
(b) any liability of Seller or any of Seller’s
Affiliates for Taxes, including any liability of Seller or any of
Seller’s Affiliates for Taxes as a result of Seller’s
operation of the
2
Business or Taxes payable by Seller or any of
Seller’s Affiliates that will arise as a result of the sale
of the Acquired Assets pursuant to this Agreement; (c) any
liability of Seller or any of Seller’s Affiliates relating to
payroll, vacation, sick leave, workers’ compensation,
unemployment benefits, pension benefits, health care plans or
benefits or other employee plans or benefits of any kind for
Seller’s employees or former employees or both, in every case
arising out of and relating to Seller’s employment of such
employees or former employees and including any liability of Seller
under any employment, severance, retention or termination agreement
with any employee of Seller or any of Seller’s Affiliates;
(d) any liability of Seller under this Agreement or other
document executed in connection with the transactions contemplated
hereby; (e) any liability of Seller based upon Seller’s
acts or omissions occurring after the Closing; (f) any
liability of Seller or any of Seller’s Affiliates arising out
of product returns in connection with discontinued product programs
where Seller or its Affiliates has received notice from a customer
as of the Closing Date that such customer intends to discontinue
carrying such product and any liabilities related to any discount
programs implemented by any such customer to liquidate any such
product (“Discontinued Product Programs”); and
(g) any amount remaining due and payable by Seller to third
parties as of the Closing Date in connection with Seller’s
acquisition of the Acquired Inventory, other than obligations of
Seller related to open purchase orders for Acquired Inventory that
are being assumed by Buyer.
“ GAAP ” means
United States generally accepted accounting principles as in effect
from time to time, consistently applied.
“ Intellectual Property
” means: (a) customer names and history, (b) vendor
names, (c) product cost history, (d) product performance,
(e) customer performance, (f) campaign performance,
(g) URLs and any Internet addresses, (h) trademarks,
service marks, trade dress, logos, slogans, trade names, Internet
domain names and telephone numbers, together with translations,
adaptations, derivations, and combinations thereof and including
goodwill associated therewith, and applications, registrations, and
renewals in connection therewith, (i) websites, graphics,
designs, labels, packaging and other copyrightable works,
copyrights, and applications, registrations, and renewals in
connection therewith, (j) product specifications, trade
secrets and confidential business information (including ideas,
research and development, know-how, formulas, compositions,
manufacturing and production processes and techniques, technical
data, designs, drawings, specifications, customer and supplier
lists, pricing and cost information and business and marketing
plans and proposals together with marketing material, point of sale
material and television commercials), (k) advertising and
promotional materials, (l) other proprietary rights, and
(m) copies and tangible embodiments thereof (in whatever form
or medium).
“ Knowledge ”
means, with respect to any representation, warranty or statement of
any Party in this Agreement that is qualified by such Party’s
“knowledge,” the actual knowledge of such Party or such
knowledge that a reasonably prudent officer, director, manager or
employee should have if such Person duly performed his or her
duties as an officer, director, manager or employee of such Party
with due care; provided, however, that the foregoing shall not be
construed to create a duty or obligation on any Person to engage in
or conduct any inquiry or investigation, and provided further that
Seller will be deemed to have Knowledge of a particular fact or
other matter only if Ken Wolf or Mark LeDoux has Knowledge of that
fact or other matter, and Buyer will be deemed to have Knowledge of
a particular fact or other matter only if Toby Browne or Michael
Halter has Knowledge of that fact or other matter.
3
“ Net Inventory Value
” means the amount equal to (a) the gross inventory
value of the Acquired Inventory as set forth on the books and
records of the Seller, which have been maintained in accordance
with GAAP, less (b) any inventory reserve balance set forth on
such books and records.
“ Person ” means
an individual, a partnership, a corporation, a limited liability
company, an association, a joint stock company, a trust, a joint
venture, an unincorporated organization, any other business entity
or a governmental entity (or any department, agency, or political
subdivision thereof).
“ Restricted Business
” means the marketing and sale of the products included in
Acquired Inventory; provided, however, that the foregoing shall not
be construed in a manner such that it in any way limits or
restricts the ability of Seller, its Parent or Affiliates from
(i) manufacturing any products for third parties, or
(ii) manufacturing, distributing or selling any products being
sold as of the Closing Date under the Dr. Cherry brand or any
other nutritional supplements or other nutraceutical, nutritional
or skin care products not included in Acquired Inventory.
Notwithstanding the foregoing part (ii), the Parties agree that,
during the Restricted Period (as hereinafter defined), neither
Seller nor its Parent or Affiliates may create, distribute and sell
a new brand of products not existing as of the Closing Date and
comprised of products substantially similar to those included in
Acquired Inventory.
“ Tax ” or
“ Taxes ” means any federal, state, local, or
foreign taxes, charges, fees, imposts or other assessments,
including those related to income, gross receipts, license,
payroll, employment, excise, severance, stamp, occupation, premium,
windfall profits, environmental (including taxes under Code
§59A), customs duties, capital stock, franchise, profits,
withholding, social security (or similar), unemployment,
disability, real property, personal property, sales, use, transfer,
registration, value added, alternative or add-on minimum,
estimated, or other tax of any kind whatsoever, whether computed on
a separate or consolidated, unitary or combined basis or in any
other manner, including any interest, penalty, or addition thereto,
whether disputed or not.
“ Tax Return ”
means any return, declaration, report, claim for refund, or
information return or statement relating to Taxes, including any
schedule or attachment thereto, and including any amendment
thereof.
Section 2. Basic
Transaction .
(a) Purchase and Sale of
Assets . On and subject to the terms and conditions of this
Agreement, Buyers agree to purchase from Seller, and Seller agrees
to sell, transfer, convey, and deliver to Buyers, all of the
Acquired Assets at the Closing for the consideration specified
below in this Section 2 .
(b) Assumption of Liabilities
. On and subject to the terms and conditions of this Agreement,
Buyers agree to assume and become responsible for all of the
Assumed Liabilities at the Closing. Buyers will not assume or have
any responsibility, however, with respect to any other obligation
or liability of Seller not included within the definition of
Assumed Liabilities.
4
(c) Purchase Price
.
(i) At the Closing, Buyer agrees to
pay to Seller $500,000 (the “ Purchase Price ”)
in United States dollars, by delivery of cash in such amount,
payable by wire transfer or delivery of other immediately available
funds. The Purchase Price is subject to adjustment as provided in
Section 2(c)(ii) below.
(ii) Purchase Price
Adjustments . No later than ten (10) business days after
the Closing Date, Seller shall provide Buyers with a final copy of
Schedule 2, setting forth the Acquired Inventory, and Exhibit
D , which shall include a statement of the Closing Date Net
Inventory Value based on such Schedule 2. The date such Schedule 2
and Exhibit D are provided by Seller to Buyers is referred
to herein as the “ Schedule 2 Delivery Date
.”
(A) If the Closing Date Net
Inventory Value is less than $265,000, then the Purchase Price
shall be decreased by an amount equal to the difference obtained by
subtracting the amount of the Closing Date Net Inventory Value from
$265,000, and Seller shall pay such difference to Buyers within
five (5) business days after the Schedule 2 Delivery
Date.
(B) If the Closing Date Net
Inventory Value is greater than $315,000, then the Purchase Price
shall be increased by an amount equal to the difference obtained by
subtracting $315,000 from the amount of the Closing Date Net
Inventory Value, and Buyers shall pay such difference to Seller
within five (5) business days after the Schedule 2 Delivery
Date.
(C) If, on the Closing Date, the
Interbank Australian Dollar exchange rate relative to the
U.S. Dollar, as reported in the Wall Street Journal, is less
than 0.665 cents, the Purchase Price shall be adjusted such that
the Purchase Price in U.S. Dollars is the equivalent of $714,286
Australian Dollars based on such Closing Date exchange
rate.
(iii) Earn-out . In addition
to the Purchase Price, Seller shall receive from Buyers, as
additional consideration for the transactions contemplated hereby,
the amounts set forth below:
(A) Within forty five (45) days
after the end of each of the three month periods ending on
October 31, 2009, January 31,
2010, April 30, 2010 and July 31, 2010, Buyers shall
calculate the Consolidated Brand Contribution Margin consistent
with the method and presentation set forth in the Consolidated
Budgeted Brand Contribution attached hereto as Exhibit H
(“ Budgeted Brand Contribution ”) and submit a
copy of such calculation to Seller. The calculation for the three
month period ending July 31, 2010 shall also include a
cumulative calculation for the period from August 1, 2009
through July 31, 2010. To the extent any expenditures of
Buyers reflected on the Consolidated Brand Contribution Margin
calculated by Buyers exceed the budgeted amounts for such
expenditures as set forth on the Budgeted Brand Contribution, and
such increases were authorized, initiated or otherwise within the
control of Buyers, including any increases resulting from an
increase in the number of employees, any change in the
nature
5
or amount of promotional activities undertaken,
or any other change in the operation of the Business as conducted
by Buyers, such excess amounts shall be added back to the Brand
Contribution Margin such that the Brand Contribution Margin shall
be calculated as if such excesses had not occurred.
(B) For each of the three month
periods ending on October 31, 2009, January 31,
2010, and April 30, 2010, Buyers shall pay to Seller an amount
equal to:
[A ÷ B] x $125,000 x
0.50
|
|
|
|
|
|
where
|
|
A =
|
|
the actual
Brand Contribution Margin for the three month period as calculated
by Buyers; and
|
|
|
|
|
|
B =
|
|
the budgeted
Brand Contribution Margin for the three month period set forth on
the Budgeted Brand Contribution.
|
(C) For the three month period
ending on July 31, 2010, Buyers shall pay to Seller an amount
equal to:
[X ÷ Y] x $500,000 -
Z
|
|
|
|
|
|
where
|
|
X =
|
|
the actual
Brand Contribution Margin for the period from August 1, 2009
through July 31, 2010 as calculated by Buyers;
|
|
|
|
|
|
Y =
|
|
the budgeted
Brand Contribution Margin for the period from August 1, 2009
through July 31, 2010 set forth on the Budgeted Brand Contribution;
and
|
|
|
|
|
|
Z =
|
|
the amount of
the payments previously paid by Buyers to Seller pursuant to
Section 2(c)(iii)(B) .
|
(D) The amounts due to Seller from
Buyers in accordance with Section 2(c)(iii)(B) and
Section 2(c)(iii)(C) shall be paid to Seller no later
than sixty (60) days after the end of each such three month
period.
(E) All computations in connection
with the Consolidated Brand Contribution Margin for purposes of
Section 2(c)(iii)(A) shall be done by Buyers in
accordance with GAAP.
(F) Seller shall be entitled to have
access to the books and records of Buyers and the work papers of
Buyers prepared in connection with the preparation and calculation
of the Consolidated Brand Contribution Margin and shall be entitled
to discuss such books and records, work papers and calculation with
Buyers and those persons responsible for the preparation
thereof.
(d) The Closing . The closing
of the transactions contemplated by this Agreement (the “
Closing ”) shall take place at the offices of K&L
Gates LLP, 3580 Carmel Mt. Road, Suite 200, San Diego, California
commencing at 9:00 a.m. local time on July 31, 2009 following
the satisfaction or waiver of all conditions to the obligations of
the Parties to consummate the transactions contemplated hereby
(other than conditions with respect to actions the respective
Parties will take at the Closing itself) or at such other place,
such other time or by such other method as the Parties may mutually
determine (the “ Closing Date ”).
6
(e) Deliveries at the Closing
. At the Closing, (i) Seller will deliver to Buyers the
various certificates, instruments, and documents referred to in
Section 6(a) below; (ii) Buyers will deliver to
Seller the various funds, certificates, instruments, and documents
referred to in Section 6(b) below; (iii) Seller
will execute, acknowledge (if appropriate), and deliver (A) to
PharmaCare US an Assignment and Bill of Sale in the form of
Exhibit A-1 , (B) to PharmaCare Australia an Assignment
and Bill of Sale in the form of Exhibit A-2 , (C) to
PharmaCare Australia a counterpart Trademark Assignment in the form
attached hereto as Exhibit C , (D) to Buyers a
counterpart Instrument of Assumption in the form attached hereto as
Exhibit B , (E) to Buyers an Assignment and Assumption
Agreement in the form attached hereto as Exhibit F , and
(F) to Buyers such other instruments of sale, transfer,
conveyance, and assignment as Buyers and their counsel may
reasonably request; (iv) Buyers will execute and deliver to
Seller a counterpart Instrument of Assumption in the form attached
hereto as Exhibit B ; (v) PharmaCare Australia will
execute and deliver to Seller a counterpart Trademark Assignment in
the form attached hereto as Exhibit C ; (vi) Buyers
will execute and deliver to Seller a counterpart Assignment and
Assumption Agreement in the form attached hereto as Exhibit
F ; (vii) Buyers will execute, acknowledge (if
appropriate), and deliver to Seller such other instruments of
assumption as Seller and its counsel may reasonably request; and
(viii) Buyers will deliver to Seller the consideration
specified in Section 2(c)(i) above (as may be adjusted
pursuant to Section 2(c)(ii) ).
(f) Purchase Price Allocation
. The Purchase Price shall be allocated among the Acquired Assets
as mutually agreed by Buyers and Seller. It is intended that such
allocation will comply with the requirements of Section 1060
of the Code. Buyers shall prepare and deliver Internal Revenue
Service (“ IRS ”) Form 8594 to Seller within
forty-five (45) days after the Closing Date to be filed with
the IRS, subject to Seller’s review and approval which shall
not be unreasonably withheld. Seller and Buyers shall file Form
8594 with their respective timely-filed Tax Returns consistent with
such allocation. The Parties shall treat and report the transaction
contemplated by this Agreement in all respects consistently for
purposes of any federal, state or local Tax, including the
calculation of gain, loss and basis with reference to the Purchase
Price allocation made pursuant to this Section 2(f) .
The Parties shall not take any action or position inconsistent with
the obligations set forth in this Agreement. Seller agrees to
indemnify and hold Buyers and their respective Affiliates harmless
and Buyers hereby agree to indemnify and hold Seller and its
Affiliates harmless, from and against any and all losses,
liabilities and expenses (including additional income taxes and
reasonable fees and disbursements of counsel) that may be incurred
by the indemnified party as a result of the failure of the
indemnifying party so to report the sale and purchase of the
Acquired Assets as required by applicable laws.
Section 3. Seller’s
Representations and Warranties . Seller represents and warrants
to Buyers that the statements contained in this
Section 3 are correct and complete as of the Effective
Date and will be correct and complete as of the Closing Date (as
though made then and as though the Closing Date were substituted
for the Effective Date throughout this Section 3 ),
except as set forth in the disclosure schedule accompanying this
Agreement (the “ Disclosure Schedule ”). The
Disclosure Schedule will be arranged in paragraphs corresponding to
the lettered and numbered paragraphs contained in this
Section 3 and the other sections of this Agreement
pursuant to which disclosure is made or items are referred to in
the Disclosure Schedule.
7
(a) Organization of Seller .
Seller is a corporation duly organized, validly existing, and in
good standing under the laws of the State of California, with full
corporate power and authority to conduct the Business as now being
conducted by it, and to own and use the properties it purports to
own and use in the conduct of the Business.
(b) Authorization of
Transaction . Seller has full corporate power and authority to
execute and deliver this Agreement and the documents contemplated
hereby (the “ Transaction Documents ”) and to
perform its obligations thereunder. This Agreement constitutes, and
the other Transaction Documents to which Seller is a party when
executed will constitute, the valid and legally binding obligation
of Seller, enforceable against it in accordance with its terms and
conditions, except as limited by applicable bankruptcy, insolvency,
reorganization, moratorium, fraudulent conveyance and other similar
laws of general application affecting enforcement of
creditors’ rights generally. The execution, delivery and
performance of the Transaction Documents to which Seller is a party
by Seller have been duly authorized by all necessary action of
Seller’s shareholder and board of directors.
(c) Non-contravention .
Neither the execution and delivery of this Agreement, nor the
consummation of the transactions contemplated hereby (including the
assignments and assumptions referred to in Section 2
above), will (i) violate any constitution, statute,
regulation, rule, injunction, judgment, order, decree, ruling,
charge, or other restriction of any government, governmental
agency, or court to which Seller or the Acquired Assets are
subject, except as set forth in Schedule 3(c) of Seller’s
Disclosure Schedule, or any provision of the charter or bylaws of
Seller, or (ii) except as set forth in Schedule 3(c) of
Seller’s Disclosure Schedule, conflict with, result in a
material breach of, constitute a default under, result in the
acceleration of, create in any party the right to accelerate,
terminate, modify, or cancel, or require any notice under any
agreement, contract, lease, license, instrument, or other
arrangement to which Seller is a party or by which it is bound or
to which any of the Acquired Assets is subject (or result in the
imposition of any lien upon any of the Acquired Assets). Except as
set forth in Schedule 3(c) of Seller’s Disclosure Schedule,
the Seller does not need to give any notice to, make any filing
with, or obtain any authorization, consent, or approval of any
government or governmental agency in order for the Parties to
consummate the transactions contemplated by this Agreement
(including the assignments and assumptions referred to in
Section 2 above).
(d) Brokers’ Fees .
Except as set forth in Schedule 3(d) of Seller’s Disclosure
Schedule, Seller has no liability or obligation to pay any fees or
commissions to any broker, finder, or agent with respect to the
transactions contemplated by this Agreement.
(e) Title to Assets . Except
as set forth in Schedule 3(e) of Seller’s Disclosure
Schedule, Seller has good title to the Acquired Assets, free and
clear of any liens or restriction on transfer, and Seller has the
right to transfer the Acquired Assets to Buyers, free and clear of
any liens or other encumbrances or liabilities.
8
(f) Selected Financial Data .
Within ten (10) business days after the Closing Date, Seller
shall prepare, deliver to Buyers and attach hereto as Exhibit
D the following financial data (the “ Selected
Financial Data ”):
(i) The Closing Date Net Inventory
Value, which shall be deemed final and conclusive and binding upon
the Seller and the Buyers for purposes of this Agreement;
and
(ii) the obligations of Seller in
respect of the Assumed Liabilities, as of the Closing
Date.
Except as set forth on Schedule 3(f)
of Seller’s Disclosure Schedule, the Selected Financial Data
will fairly present the values, obligations and expenses set forth
therein and will be based upon the books and records of Seller,
which have been maintained in accordance with GAAP.
(g) Acquired Intellectual
Property .
(i) Except as set forth on Schedule
3(g)(i) of Seller’s Disclosure Schedule, to Seller’s
Knowledge: (a) no third party has interfered with, infringed
upon, misappropriated, or violated the Acquired Intellectual
Property; (b) no Acquired Intellectual Property interferes
with, infringes upon or violates the intellectual property rights
of any third-party; (c) no copyrighted or copyrightable
material included in the Acquired Intellectual Property infringes
upon or violates the copyrights of any third party; and (d) no
know-how, process, or product included in the Acquired Intellectual
Property violates any trade secret of any third party.
(ii) Schedule 3(g)(ii) of the
Disclosure Schedule identifies: (a) each license, agreement,
or other permission that Seller has granted to any third party with
respect to any of the Acquired Intellectual Property (together with
any exceptions); and (b) each license, agreement, or other
permission that has been granted to Seller with respect to any of
the Acquired Intellectual Property. With respect to each item
required to be disclosed on Section 3(g)(ii) of the
Disclosure Schedule, as well as each other item of Acquired
Intellectual Property:
(A) Except as set forth on Schedule
3(g)(ii)(A) of Seller’s Disclosure Schedule, Seller possesses
all right, title, and interest in and to the item, free and clear
of any lien, license, or other restriction, and Seller is not
obligated to pay any royalties with respect thereto;
(B) Except as set forth on Schedule
3(g)(ii)(B) of Seller’s Disclosure Schedule, the item is not
subject to any outstanding injunction, judgment, order, decree,
ruling, or charge;
(C) Except as set forth on Schedule
3(g)(ii)(C) of Seller’s Disclosure Schedule, no action, suit,
proceeding, hearing, charge, complaint, claim, or demand is pending
nor, to Seller’s Knowledge, is threatened, nor has Seller
received notice of the commencement of any